Sukhmandeep Baidwan, MD
Psychiatry · French Camp
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 15 years
- Graduated 2011
Offices
2 locations · San Joaquin Faculty Medical Group · Community Health Centers of America
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baidwan’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A166420 · Current
Licensed to practise in California · since 2019 · expires 2027-10-31 · Manipal Academy of Higher Education Kasturba Medical College Mangalore.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$25,706
Medicare paid this office $25,706 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $15,535 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $5,234 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $4,337 | $136 |
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 50 · Under 65 76% · Women 45% · Also on Medicaid 87% · Health risk score 1.12. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 61% · High blood pressure 55% · Diabetes 25% · COPD 13%.
The office billed $77,144, Medicare allowed $33,152 and paid $25,706; for 346 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 346 | 50 | 1.12 | $77,144 | $25,706 |
| 2023 | 31 | 105 | 47 | 1.13 | $26,753 | $10,009 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $8,903 | $97 |
Medicaid work
$28,314 in 2024
Medicaid paid $28,314 for 677 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 114 | $17,605 |
| Long return visit (40+ min) | 222 | $9,706 |
| Return visit (30+ min) | 39 | $927 |
| Short return visit (20+ min) | 12 | $75 |
| TOBACCO NON-USER | 124 | $0 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 121 | $0 |
| Alcohol and/or drug screening | 45 | $0 |
| 2024 | 677 | 7 | 87 | $28,314 |
| 2023 | 1,357 | 7 | 59 | $30,803 |
| 2022 | 123 | 1 | 24 | $12,744 |
| 2021 | 37 | 1 | 19 | $3,834 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 204 | $29,624 |
| Return visit (30+ min) | 334 | $606 |
| Psychiatric diagnostic evaluation with medical services | 26 | $573 |
| TOBACCO NON-USER | 195 | $0 |
| Medication list documented in medical record (COA) | 261 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 264 | $0 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 73 | $0 |
2022
| Return visit (30+ min) | 123 | $12,744 |
2021
| Return visit (30+ min) | 37 | $3,834 |
Drugs they prescribed that Part D paid
$7,050
Pharmacies billed $7,050 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 200) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
199 generic and fewer than 11 brand-name prescriptions · $7,050 in drug cost · 16 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 13 | $2,566 | $197 |
| Duloxetine | 14 | $372 | $27 |
| Quetiapine | 19 | $304 | $16 |
| Divalproex | 12 | $262 | $22 |
| Sertraline | 16 | $96 | $6 |
See all 6 drugs
| Aripiprazole | 13 | $2,566 | $197 |
| Duloxetine | 14 | $372 | $27 |
| Quetiapine | 19 | $304 | $16 |
| Divalproex | 12 | $262 | $22 |
| Sertraline | 16 | $96 | $6 |
| Donepezil | 11 | $50 | $5 |
Year by year
| 2024 | 200 | 33 | 0% (0) | None | $7,050 |
| 2023 | 291 | 54 | 0% (0) | 5% | $37,422 |
| 2022 | 996 | 102 | 0% (0) | 7% | $108,984 |
| 2021 | 1,226 | 126 | 0% (0) | 10% | $169,023 |
| 2020 | 677 | 88 | 0% (0) | 10% | $101,551 |
| 2019 | 27 | None | 0% (0) | 0% | $400 |
| 2017 | 60 | 23 | 0% (0) | None | $1,700 |
| 2016 | 13 | None | 0% (0) | None | $1,040 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Aripiprazole | 22 | $3,757 | $171 |
| Quetiapine | 19 | $1,272 | $67 |
| Duloxetine | 19 | $837 | $44 |
| Divalproex Sodium Er | 12 | $791 | $66 |
| Buspirone | 24 | $517 | $22 |
| Mirtazapine | 12 | $344 | $29 |
| Venlafaxine Hcl Er | 15 | $331 | $22 |
| Hydroxyzine Pamoate | 14 | $158 | $11 |
| Valproic Acid | 11 | $134 | $12 |
| Sertraline | 21 | $124 | $6 |
| Fluoxetine | 12 | $101 | $8 |
2022: 28 drugs
| Divalproex Sodium Er | 51 | $4,383 | $86 |
| Quetiapine | 74 | $3,821 | $52 |
| Aripiprazole | 20 | $3,593 | $180 |
| Ziprasidone | 30 | $3,401 | $113 |
| Olanzapine | 46 | $2,677 | $58 |
| Olanzapine Odt | 11 | $1,434 | $130 |
| Benztropine Mesylate | 21 | $1,392 | $66 |
| Clozapine | 24 | $1,273 | $53 |
| Venlafaxine Hcl Er | 66 | $1,128 | $17 |
| Duloxetine | 39 | $807 | $21 |
| Divalproex | 18 | $792 | $44 |
| Mirtazapine | 28 | $790 | $28 |
| Trazodone | 60 | $771 | $13 |
| Fluoxetine | 66 | $650 | $10 |
| Haloperidol | 21 | $549 | $26 |
| Risperidone | 26 | $524 | $20 |
| Haloperidol Lactate | 13 | $478 | $37 |
| Prazosin | 19 | $363 | $19 |
| Sertraline | 24 | $342 | $14 |
| Gabapentin | 13 | $258 | $20 |
| Topiramate | 17 | $230 | $14 |
| Alprazolam | 12 | $208 | $17 |
| Atorvastatin | 13 | $166 | $13 |
| Hydroxyzine Pamoate | 21 | $149 | $7 |
| Lorazepam | 24 | $143 | $6 |
| Levothyroxine | 11 | $135 | $12 |
| Propranolol | 14 | $120 | $9 |
| Memantine | 11 | $92 | $8 |
2021: 30 drugs
| Vraylar | 36 | $42,456 | $1,179 |
| Rexulti | 11 | $14,464 | $1,315 |
| Aripiprazole | 22 | $4,876 | $222 |
| Divalproex Sodium Er | 48 | $4,207 | $88 |
| Ziprasidone | 26 | $3,460 | $133 |
| Quetiapine | 97 | $3,333 | $34 |
| Venlafaxine Hcl Er | 99 | $2,363 | $24 |
| Mirtazapine | 67 | $2,154 | $32 |
| Clozapine | 44 | $1,464 | $33 |
| Duloxetine | 55 | $1,437 | $26 |
| Divalproex | 30 | $1,420 | $47 |
| Trazodone | 53 | $1,228 | $23 |
| Fluoxetine | 54 | $1,009 | $19 |
| Bupropion Xl | 18 | $562 | $31 |
| Olanzapine | 24 | $474 | $20 |
| Escitalopram | 36 | $442 | $12 |
| Risperidone | 20 | $431 | $22 |
| Prazosin | 19 | $423 | $22 |
| Benztropine Mesylate | 45 | $360 | $8 |
| Levothyroxine | 22 | $290 | $13 |
| Lithium Carbonate | 13 | $173 | $13 |
| Hydroxyzine Pamoate | 21 | $161 | $8 |
| Lamotrigine | 21 | $152 | $7 |
| Propranolol | 14 | $114 | $8 |
| Sertraline | 16 | $113 | $7 |
| Pantoprazole | 14 | $108 | $8 |
| Topiramate | 17 | $103 | $6 |
| Metformin | 14 | $73 | $5 |
| Lorazepam | 14 | $68 | $5 |
| Citalopram Hbr | 17 | $68 | $4 |
2020: 20 drugs
| Caplyta | 18 | $23,752 | $1,320 |
| Rexulti | 12 | $14,524 | $1,210 |
| Latuda | 11 | $14,123 | $1,284 |
| Venlafaxine Hcl Er | 61 | $3,304 | $54 |
| Mirtazapine | 63 | $1,949 | $31 |
| Divalproex Sodium Er | 12 | $884 | $74 |
| Trazodone | 59 | $719 | $12 |
| Quetiapine | 59 | $656 | $11 |
| Duloxetine | 34 | $633 | $19 |
| Olanzapine | 21 | $440 | $21 |
| Hydroxyzine Pamoate | 31 | $249 | $8 |
| Risperidone | 17 | $211 | $12 |
| Fluoxetine | 32 | $196 | $6 |
| Prazosin | 12 | $193 | $16 |
| Escitalopram | 27 | $145 | $5 |
| Sertraline | 21 | $136 | $6 |
| Lithium Carbonate | 11 | $125 | $11 |
| Gabapentin | 11 | $108 | $10 |
| Citalopram Hbr | 19 | $104 | $5 |
| Lamotrigine | 14 | $50 | $4 |
Money from drug and device companies
$103 in 2023
| 2023 | 2 | 6 | None | $103 |
| 2022 | 6 | 12 | None | $242 |
| 2021 | 13 | 74 | None | $1,369 |
| 2020 | 5 | 13 | None | $271 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 6 published payments
| AbbVie | Meals · 2023-05-23 | Vraylar | $16 |
| AbbVie | Meals · 2023-04-11 | Vraylar | $16 |
| AbbVie | Meals · 2023-03-21 | Vraylar | $16 |
| AbbVie | Meals · 2023-01-31 | Vraylar | $15 |
| Iti | Meals · 2023-01-11 | Caplyta | $19 |
| AbbVie | Meals · 2023-01-10 | Vraylar | $22 |
See earlier years (2022, 2021, 2020)
2022: $242
| Abbvie | Vraylar | $101 | 5 payments
|
| Iti | Caplyta | $56 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $25 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $22 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $21 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $17 | 1 payment
|
2021: $1,369
| AbbVie | Vraylar | $378 | 18 payments
|
| Iti | Caplyta | $316 | 24 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $194 | 9 payments
|
| Otsuka America Pharmaceutical | Abilify Mycite | $103 | 5 payments
|
| Lundbeck | Brintellix | $71 | 3 payments
|
| Indivior | Perseris | $71 | 3 payments
|
| Merck Sharp & Dohme | Belsomra | $46 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $45 | 2 payments
|
| Eisai | Dayvigo | $36 | 2 payments
|
| Bausch Health US | Aplenzin | $33 | 2 payments
|
| Avanir Pharmaceuticals | Nuedexta | $29 | 2 payments
|
| Alkermes | Aristada | $25 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $22 | 1 payment
|
2020: $271
| Allergan | Vraylar | $125 | 6 payments
|
| Iti | Caplyta | $58 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $43 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $24 | 1 payment
|
| Noven Therapeutics | Secuado | $21 | 1 payment
|
Professional record
- NPI
- 1346695004
- Licence
- CA A166420California A166420: Current · expires 2027-10-31
- Group
- San Joaquin Faculty Medical Group · Community Health Centers of America
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 8880 Cal Center Dr Ste 400, Sacramento, CA, 95826
- NPI first listed
- 2016-05-02
- NPI last updated
- 2025-03-17
- NPI record certified
- 2025-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9343 Tech Center Dr Ste 110, Sacramento, CA, 95826